Year: 2011
Type: review
Study design: Systematic Review
Abstract: Dengue vaccines are currently in development and policymakers need appropriate economic studies to determine their potential financial and public health impact. We searched five databases (PubMed, EMBASE, LILAC, EconLit, and WHOLIS) to identify health economics studies of dengue. Forty-three manuscripts were identified that provided primary data: 32 report economic burden of dengue and nine are comparative economic analyses assessing various interventions. The remaining two were a willingness-to-pay study and a policymaker survey. An expert panel reviewed the existing dengue economic literature and recommended future research to fill information gaps. Although dengue is an important vector-borne disease, the economic literature is relatively sparse and results have often been conflicting because of use of inconsistent assumptions. Health economic research specific to dengue is urgently needed to ensure informed decision making on the various options for controlling and preventing this disease.
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: United States Agency for International Development, Bill and Melinda Gates Foundation, GlaxoSmithKline, Sanofi, World Health Organization, Brandeis University, Université de Lille, Universiteit Antwerpen, Robert Koch Institut, Centers for Disease Control and Prevention, Sanofi Pasteur, National Center for Preparedness, Detection, and Control of Infectious Diseases
OpenAlex ID: W2149292001